Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Rivian shares fell 0.9% to $19.42 in premarket trading Wednesday after a 5.2% drop the previous session. CEO R.J. Scaringe sold 17,450 shares on Dec. 23 under a pre-arranged plan, according to a regulatory filing. Investors are awaiting Rivian’s quarterly production and delivery update and Tesla’s delivery report for signs of electric-vehicle demand.
XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng shares dropped 4.2% to $20.38 in premarket trading Wednesday, reversing a 3.8% gain from the previous session. The move followed China’s announcement of 62.5 billion yuan in 2026 trade-in subsidies for consumer goods, including new-energy vehicles. CEO He Xiaopeng detailed plans for a range-extended G7 model set to debut in early 2026.
TSMC stock today: Taiwan Semi slips premarket on Nvidia H200 supply talks and a 2nm production update

TSMC stock today: Taiwan Semi slips premarket on Nvidia H200 supply talks and a 2nm production update

TSMC’s U.S.-listed shares fell 0.4% to $299.58 in premarket trading after Reuters reported Nvidia asked the chipmaker to expand H200 AI chip production for Chinese buyers. Chinese firms have ordered over 2 million H200 chips for 2026, with pricing near $27,000 each. TSMC also said it began volume production of its 2nm chips in Q4.
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers Health shares fell 0.5% to $32.87 in premarket trading Wednesday after closing down 3.1% the previous session. The move follows price cuts by Novo Nordisk and Eli Lilly on obesity drugs in China, raising questions about future margins and demand for GLP-1 therapies. Hims recently launched its weight-loss membership in the UK, offering access to Wegovy and Mounjaro.
Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Oriental Culture Holding shares rose 1.8% to $0.104 in premarket trading Wednesday after a 23% jump Tuesday, with 342 million shares traded. The company disclosed recent share sales under a $200 million at-the-market program and shareholder approval for a possible reverse split. Traders are watching dilution risk and compliance steps as the stock’s 52-week range spans $0.07 to $19.29.
31 December 2025
iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen Inc shares fell about 15% to $0.30 premarket after announcing a $5.5 million private placement of Series C convertible preferred stock. The preferred converts to common shares at a 15% discount to the prior day’s close, raising dilution concerns. The company remains below Nasdaq’s $1 minimum bid, with a compliance deadline of May 2026. Financing is expected to close Wednesday.
31 December 2025
Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital Holdings shares jumped about 35% in premarket trading after the company disclosed its special shareholder meeting was adjourned for lack of quorum and rescheduled to Dec. 30. Investors are watching a pending vote on a reverse stock split and share-issuance proposals needed to meet Nasdaq’s $1 minimum bid requirement. The company faces a Jan. 30, 2026 deadline to regain compliance or risk delisting.
31 December 2025
Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics shares fell 8.3% to $9.70 premarket after surging 93.8% Tuesday, following Applied Digital’s plan to merge its cloud unit with Ekso to form ChronoScale. The companies signed a non-binding term sheet, with Applied Digital set to own about 97% of the combined firm. Investors await binding terms, financing details, and SEC filings ahead of a shareholder vote.
Oriental Rise (ORIS) stock jumps premarket after Daguan Tea acquisition LOI

Oriental Rise (ORIS) stock jumps premarket after Daguan Tea acquisition LOI

NEW YORK, December 31, 2025, 05:13 ET — Premarket Shares of Oriental Rise Holdings Limited jumped 36.9% to $1.67 in premarket trading on Wednesday after the China-based tea supplier said it signed a non-binding letter of intent to acquire a controlling equity interest in Hubei Daguan Tea Industry Group. Public+1 The proposed move matters now because it aims at a pressure point for food-and-beverage producers: securing reliable inputs while controlling costs. Oriental Rise pitched the deal as part of a “vertical integration” strategy—owning more steps of the supply chain, from cultivation and processing to downstream sales—to improve margins over time.
31 December 2025
AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

Aimei Health Technology shares jumped 38% to $114 in premarket trading Wednesday, after closing up 89% at $82.58 Tuesday. The surge follows a sharp reduction in outstanding shares after nearly 4 million were redeemed this month, leaving about 2.18 million shares. Trading volume Tuesday was four times the recent average. The company faces a Jan. 6, 2026, deadline to complete its merger with United Hydrogen Group.
31 December 2025
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa shares fell about 12% to 10.7 cents in premarket trading Wednesday after a 78% surge the previous day. The company raised the conversion floor on its senior secured convertible notes to $0.35 and eliminated mandatory amortization payments. A filing outlined conditions for up to $5 million in new note financing and referenced a possible reverse stock split in January 2026.
31 December 2025
Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharmaceuticals shares rose about 18% in premarket trading after the FDA approved its motion-sickness drug Nereus (tradipitant). The company plans to launch the oral treatment in the coming months. The approval followed late-stage trials involving 681 patients. Shares closed at $7.03 Tuesday and were indicated around $8.30 early Wednesday.

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop